Iron Horse Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Iron Horse Wealth Management's MRNA Position: Q1 2025 in Review
Iron Horse Wealth Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 12 shares — an estimated $499 sold.
Iron Horse Wealth Management first reported a position in MRNA in Q3 2023 and held it in 6 quarters. The position peaked at $1.43K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.
- Iron Horse Wealth Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
- Iron Horse Wealth Management sold 12 Moderna shares in Q1 2025, an estimated $499.
- Iron Horse Wealth Management first reported a position in Moderna in Q3 2023 and held it in 6 quarters.
- Iron Horse Wealth Management's Moderna position peaked at $1.43K in Q2 2024.
- 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.
Based on Iron Horse Wealth Management's 13F filing for Q1 2025, filed 1 May 2025.